1.
Int J Antimicrob Agents
; 57(1): 106242, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1065139
Subject(s)
Antiviral Agents/therapeutic use , Azithromycin/therapeutic use , COVID-19 Drug Treatment , Hydroxychloroquine/therapeutic use , SARS-CoV-2/drug effects , Anti-Bacterial Agents/therapeutic use , Antimalarials/therapeutic use , COVID-19/virology , Clinical Trials as Topic , Drug Combinations , Drug Interactions , Drug Repositioning , Drug Synergism , Electrocardiography , Humans , Hyperkalemia/prevention & control , Hypokalemia/prevention & control , Long QT Syndrome/prevention & control , Magnesium/administration & dosage , Patient Safety , RNA, Viral/antagonists & inhibitors , RNA, Viral/genetics , SARS-CoV-2/genetics , SARS-CoV-2/pathogenicity , Treatment Outcome
2.
Int J Antimicrob Agents
; 57(1): 106236, 2021 Jan.
Article
in English
| MEDLINE | ID: covidwho-1065133